The NIH may be one step closer to the holy grail of vaccines: the universal flu shot. Using the mRNA...
CNBC’s Joe Kernen gave Moderna’s CEO Stephane Bancel a tough interview, asking how he could justify taking an income of...
A judge has ruled against vaccine-maker Moderna in a case that will have ramifications over medical patents. Despite having the...
